^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
ZG19018
i
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Suzhou Zelgen
Drug class:
KRAS G12C inhibitor
Related drugs:
Phase 1/2
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Recruiting
Last update posted :
02/01/2024
Initiation :
05/26/2022
Primary completion :
05/01/2025
Completion :
05/01/2025
KRAS
|
ZG19018
Share
